FDA accepts application for Roche’s Gazyva/Gazyvaro for the treatment of the most common form of lupus
The FDA has accepted Roche’s supplemental application for Gazyva/Gazyvaro as a treatment…
Roche inaugurates new research home for the Institute of Human Biology
Roche has opened a new research facility for its Institute of Human…
Roche Announces Retirement of Key Executives
Roche announced that Johannes (Hans) Clevers (1957), M.D., Ph.D., Head of Roche…
Two Days to Go, London Biotechnology Show 2025 Gears Up to Spotlight Industry Pioneers, DisruptiveTech, Emerging Innovators
In just two days, the second edition of the London Biotechnology Show…
SRTI Park and Roche Diagnostics Middle East partner to drive sustainability and healthcare innovation
SHARJAH, UAE, April21 , 2025: Sharjah Research, Technology, and Innovation Park (SRTI Park) has…
Roche debuts cobas® Mass Spec solution to advance diagnostic technology
Basel- December 2024- Roche announced that it has received CE mark approval…
DHA highlights AI drive and diagnostic advancements in healthcare
Dubai, UAE- December 2024- The Dubai Health Authority (DHA), in collaboration with…
Roche opens Pharma Research and Development Center in Basel
Basel- September 2024 - Roche announced the opening of its new Pharma…
Breakthrough Test for B-Cell Lymphoma: One Step Closer to a Cure?
Basel- 20 June 2024- Roche announced the launch of the first clinically…
Changes to the Roche Enlarged Corporate Executive Committee
Basel, May 2024 - Roche announced that James Sabry (1958), Head of…
